Cronos News

Please Note: Press releases contained on this website are for historical purposes only and that while information contained within the releases was believed to be accurate at the time of issue, the Company will not, and specifically disclaims any duty to, update this information.

Conference Call

Cronos Group will host a conference call and webcast today, Friday, December 7 at 8:30 a.m. ET to discuss today’s announcement.

Toll-free dial-in number: (888) 231-8191
International dial-in number: (647) 427-7450
Conference ID: 9359909

A replay of the conference call will be available for approximately two weeks, from December 7, 2018 through December 21, 2018, and can be accessed by dialing (855) 859-2056 and providing the 9359909 confirmation code.

Toll-free dial-in number: (855) 859-2056
Passcode: 9359909

Conference Call

Cronos Group will host a conference call and webcast today, Friday, December 7 at 8:30 a.m. ET to discuss today’s announcement.

Toll-free dial-in number: (888) 231-8191
International dial-in number: (647) 427-7450
Conference ID: 9359909

A replay of the conference call will be available for approximately two weeks, from December 7, 2018 through December 21, 2018, and can be accessed by dialing (855) 859-2056 and providing the 9359909 confirmation code.

Toll-free dial-in number: (855) 859-2056
Passcode: 9359909

PharmaCan Capital Obtains $750,000 Bridge Financing

NOT FOR DISSENMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES TORONTO, June 29th, 2015 PharmaCan Capital Corp. (TSX-V: MJN) (“PharmaCan" or the “Company”) is pleased to announce that it has arranged a $750,000 bridge loan which is non-...

read more

PharmaCan Capital Corp.: News Release

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES Peace Naturals Project Inc. With PharmaCan’s assistance Peace Naturals has obtained a $4 million mortgage financing to further the expansion of its production capacity. Peace is...

read more

PharmaCan Capital Lends to Medical Marijuana LPs Under the MMPR

        TORONTO, ONTARIO--(Marketwired - Sept. 6, 2016) - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES PharmaCan Capital Corp. (TSX VENTURE:MJN) ("PharmaCan" or "the Company") is pleased to announce that it has become the first...

read more

Financial Statements

Unaudited Consolidated Financial reports and Management’s Discussion and Analysis reports for Cronos Group will be posted here quarterly. Please visit SEDAR for a complete listing of corporate filings and archived filings for Cronos Group Inc.

Financial Statements

Unaudited Consolidated Financial reports and Management’s Discussion and Analysis reports for Cronos Group will be posted here quarterly. Please visit SEDAR for a complete listing of corporate filings and archived filings for Cronos Group Inc.

2017
2017 – Q1 Interim Condensed Financial Statements 2017 – Q1 Management’s Discussion and Analysis (MD&A) 2017 – Q2 Interim Condensed Financial Statements 2017 – Q2 Management’s Discussion and Analysis (MD&A) 2017 – Q3 Interim Condensed Financial Statements 2017 – Q3 Management’s Discussion and Analysis (MD&A) 2017 – Annual Information Form  PDF 2017 – Year End Consolidated Financial Statements  PDF 2017 – Year End Management’s Discussion and Analysis (MD&A)  PDF Year End Notice of Record and Meeting Date  PDF ______________________________________________ XBRL Instance Document (XML) XBRL Taxonomy Extension Calculation Linkbase (XML) XBRL Taxonomy Extension Definition Linkbase (XML) XBRL Taxonomy Extension Label Linkbase (XML) XBRL Taxonomy Extension Presentation Linkbase (XML) XBRL Taxonomy Extension Schema (XSD)

720 King Street West, Suite 320

Toronto, Ontario M5V 2T3

Info@TheCronosGroup.com
Careers@TheCronosGroup.com

(416) 504-0004